Beyond the Blockbuster: How tomorrow’s patent cliff shapes today’s biopharma dealmaking?
Beyond the Blockbuster: How tomorrow’s patent cliff shapes today’s biopharma dealmaking?

Beyond the Blockbuster: How tomorrow’s patent cliff shapes today’s biopharma dealmaking

09 December 2026
Online

Every successful blockbuster creates a looming strategic challenge: how to sustain growth as flagship products approach loss of exclusivity. Pharma companies respond with different combinations of franchise management, internal R&D, and external innovation, but it's their dealmaking decisions that most directly shape opportunities across the broader biopharma innovation ecosystem. Drawing on Ipsos' newly published Replacement Architecture framework, this Virtual Salon co-produced by Demy Colton and Biotech Gate will explore what drives Pharma's partnering strategies in the wake of blockbuster success, and how Biotech companies can use those insights to identify the right partners. 

Speakers:

  • Joel Sandler, Associate Partner | Healthcare Advisory, Ipsos (Moderator)
  • Michael King Jr., Director, Research & Senior Biotechnology Analyst, Rodman & Renshaw
  • Linda Pullan , Founder & Business Development Consultant, Pullan Consulting 

To join us, please register here!


Other events